Like System Analytic Ltd.

closed 12/16/2015 via BNC Analysis

Sudler & Hennessey, acquired System Analytic Ltd.

synopsis: Sudler & Hennessey, has acquired a majority stake in System Analytic for an undisclosed sum. Sudler is a global healthcare marketing and communications network, while London-based System Analytic’s database and online tools enable pharmaceutical companies to identify, map and engage key opinions leaders across a broad range of medical fields.
buyer parent: WPP Group, plc
buyer: Sudler & Hennessey
Sudler & Hennessey is one of the world's leading healthcare communications firms, developing strategic promotional and educational programmes for a broad array of healthcare brands. "
target: System Analytic Ltd.
System Analytic Ltd. owns and operates a database and online tools to help pharmaceutical companies to identify and engages opinion leaders. The company was incorporated in 2006 and is based in London, United Kingdom.
price ($mm)
rev ($mm)
$3
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
announced 8/26/2015 via Company Press Release

Inovalon, Inc., will acquire Avalere Health LLC

synopsis: Inovalon, a leading technology company providing cloud-based analytics and data-driven intervention platforms to the healthcare industry, has entered into a definitive agreement to acquire Avalere Health, Inc., a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
buyer: Inovalon, Inc. (INOV:$449.36)
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. "
target: Avalere Health LLC
Avalere Health, Inc. is a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
price ($mm)
$140
rev ($mm)
$47
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 7/10/2007 via

Providence Equity Partners Inc., acquired Decision Resources, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announced today that Providence Equity Partners, a leading private equity firm with more than $21 billion under management, will acquire majority control of the Company.
buyer: Providence Equity Partners Inc.
Providence Equity Partners Inc. is a private investment firm specializing in equity investments in communications and media companies around the world. The principals of Providence Equity manage funds with approximately $21 billion in equity commitments. "
target parent: Boston Ventures Management, Inc.
target: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/6/2004 via PR Newswire

Boston Ventures Management, Inc., Castanea Partners, acquired Decision Resources, Inc.

synopsis: Castanea Partners and Boston Ventures Limited Partnership VI today announced the recapitalization of Decision Resources, Inc., with a total transaction value of $58 million. The Waltham, Massachusetts-based company is best known for its therapeutically-focused analyses of global pharmaceutical and biotechnology markets.
buyer: Boston Ventures Management, Inc.
buyer: Castanea Partners
Boston Ventures Management, LLC is a private equity firm that has been an active investor and financial partner to management teams in the media, entertainment, publishing and information and communications sectors since 1983, earning the firm a franchise position in the private equity community. "
target: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
price ($mm)
$58
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/25/2006 via PR Newswire

Publicis Groupe SA, acquired The Boz Group

synopsis: Publicis Groupe announced the acquisition of the BOZ Group, one of France's leading healthcare communication agencies. By joining the Publicis Healthcare Communications Group, worldwide leader in healthcare communications, BOZ will now be able to achieve its ambition of becoming a top player in Europe.
buyer: Publicis Groupe SA (ENXTPA:PUB:$12,693.26)
Publicis Groupe is the world's fourth largest communications group, as well as world's second largest media counsel and buying group. Groupe's communication activities cover advertising, through three autonomous global advertising networks: Leo Burnett, Publicis, and Saatchi & Saatchi. "
target: The Boz Group
The Boz Group was founded in 1969, and has been France's leading agency in healthcare communications for more than 25 years. This agency employs 65 people.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/9/2021 via Company Press Release

Telstra Health, will acquire MedicalDirector

synopsis: Telstra announced that Telstra Health has entered into a binding agreement to acquire leading GP clinical and practice management software company MedicalDirector. MedicalDirector has been trusted by healthcare practitioners for over 25 years, providing software as a service and innovation to the healthcare industry.
buyer parent: Telstra Corporation Limited
buyer: Telstra Health (ASX:TLS:$20,666.75)
Telstra Health is Australia's largest ehealth company. Telstra Health provides technology solutions that help improve the quality, efficiency and security of health services. They offer products and solutions for electronic medical records, telehealth, back office, medication management and more. "
target parent: Affinity Equity Partners
target: MedicalDirector
MedicalDirector has been trusted by healthcare practitioners for over 25 years, providing software as a service and innovation to the healthcare industry, including across electronic health records, patient and practice management, billing, scheduling, care coordination, and clinical content.
price ($mm)
$257
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2019 via BusinessWire

Xcenda, acquired Dymaxium, Inc.

synopsis: Xcenda, a part of AmerisourceBergen, announced the acquisition of Dymaxium, a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
buyer parent: AmerisourceBergen Corporation
buyer: Xcenda
Xcenda, part of AmerisourceBergen, is a strategic consultancy with 20+ years of experience applying real-world expertise in health economics and outcomes research, reimbursement, stakeholder insights, and market access consulting and communications. "
target: Dymaxium, Inc.
Dymaxium is a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/7/2016 via BNC Analysis

M3, Inc., will acquire Vidal Group

synopsis: Electra Partners’ portfolio company AXIO Group has received a binding offer from M3 Inc. to purchase Vidal Group, a European provider of reference drug information. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients with on-line access to up-to-date drug databases and related treatment-based information.
buyer: M3, Inc. (TSE:2413:$1,127.03)
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet. "
target parent: Electra Partners LLP
target: Vidal Group
Vidal Group is a leading European healthcare informatics and information systems company. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients across Europe with on-line access to up-to-date drug databases and related treatment-based information.
price ($mm)
$133
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/18/2016 via BNC Analysis

Affinity Equity Partners, acquired MedicalDirector

synopsis: Leading Asian private equity firm Affinity Equity Partners has acquired Sydney-based MedicalDirector (formerly Health Communication Network) from Australia’s Primary Health Care Ltd. MedicalDirector is a leading provider of clinical and enterprise software solutions to general practitioners, medical specialists and allied health professionals.
buyer: Affinity Equity Partners
Affinity Equity Partners is an independently-owned buyout fund manager comprising primarily the former investment professionals of UBS Capital Asia Pacific. They are pioneers in buyout investments in the Asia-Pacific region, with an established and widely recognised franchise. "
target parent: Primary Health Care Limited
target: MedicalDirector
MedicalDirector has been supporting healthcare professionals and improving health outcomes for more than 20 years. They provide software for practice management, optimizing patient outcomes, and access to Australia's most comprehensive and up-to-date pharmaceutical database.
price ($mm)
$119
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/11/2012 via BNC Analysis

Piramal Healthcare Limited, acquired Decision Resources Group

synopsis: Piramal Healthcare Limited has completed its previously announced acquisition of Decision Resources Group, a US based company in the healthcare information segment. Decision Resources Group is a cohesive portfolio of companies that offers best in class, high-value information and insights on important sectors of the healthcare industry.
buyer parent: Piramal Group
buyer: Piramal Healthcare Limited
With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries. "
target parent: Providence Equity Partners Inc.
target: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
price ($mm)
$635
rev ($mm)
$160
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 7/22/2010 via Company Press Release

CT Corsearch, acquired Edital

synopsis: CT Corsearch, the premier provider of clearance and protection solutions for trademark and brand professionals, announced it’s acquired Edital, the Questel trademark branch. This acquisition will create best-in-class solutions for managing a brand lifecycle globally—from creation to watching to protecting, maintaining and renewing a brand.
buyer parent: Wolters Kluwer NV
buyer: CT Corsearch
CT Corsearch provides high-quality, intuitive tools and expertise that trademark professionals need to effectively manage the trademark screening, search review and watching processes. "
target parent: Questel
target: Edital
Edital was established in Brussels in 1982 and acquired by Questel, a world leader in Intellectual Property in 2005. Its sole purpose has been to create global solutions for the Intellectual Property professional.
price ($mm)
rev ($mm)
$8
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 9/27/2007 via PR Newswire

Thomson Pharma, acquired Prous Science

synopsis: The Thomson Corporation, a leading provider of information solutions to business and professional customers worldwide, today announced that it has acquired Prous Science, a global leader in the provision of life sciences information solutions. Prous Science will become part of Thomson Scientific.
buyer parent: The Thomson Corporation
buyer: Thomson Pharma (:$1,614.03)
Thomson Scientific & Healthcare provides integrated information solutions to researchers and librarians, physicians and pharmacists, and other professionals worldwide. "
target: Prous Science
Prous Science is a trusted source of information on which science depends to discover safer and more effective medicines. The company's products have evolved through the years from print journals to sophisticated electronic products incorporating the latest advances in IT.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2007 via Company Description

MergerMarket, acquired Infinata, Inc.

synopsis: In September 2007, Mergermarket acquired Infinata, an information solutions and marketing analytics provider to the global financial service, life science, and high technology industries.
buyer parent: Pearson plc
buyer: MergerMarket
MergerMarket, part of Pearson's Financial Times Group, is an unparalleled, independent M&A intelligence tool used by the world's foremost financial institutions to originate deals. It provides proprietary intelligence on potential deal flow, potential mandates and valuations. "
target: Infinata, Inc.
Infinata is an innovative provider of information solutions and marketing analytics to the global financial service, life science, and high-tech industries. Our information suites include: BioPharm Insight, High Net Worth Insight, and Corporate Tracker.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/7/2019 via BNC Analysis

Inflexion Private Equity Partners LLP, will acquire Pharmaspectra

synopsis: Inflexion Private Equity, a UK mid-market private equity firm, will acquire Pharmaspectra, a global provider of medical affairs data to the pharmaceutical and biotech industry. Pharmaspectra offers the world's largest database for medical scientific literature and biomedical literature.
buyer: Inflexion Private Equity Partners LLP
Inflexion is a UK mid-market private equity firm. They invest in high growth, entrepreneurial businesses and work with them to accelerate growth. Inflexion’s flexible approach allows it to back both majority and minority investments, typically investing £10m to £150m of equity in each deal. "
target: Pharmaspectra
Pharmaspectra is a global provider of medical affairs data to the pharmaceutical and biotech industry. Pharmaspectra offers the world's largest database for medical scientific literature and biomedical literature. Their web-based solutions analyze data across the entire medical continuum.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/3/2013 via Company Press Release

JISC Collections, acquired SpringerProtocols

synopsis: Springer announced that JISC Collections has purchased the archive content of SpringerProtocols; the world’s largest database of life sciences protocols. SpringerProtocols contains more than 31,000 protocols, most of which come from the classic book series “Methods in Molecular Biology”.
buyer: JISC Collections
JISC Collections supports the procurement of digital content for education and research in the UK. They are uniquely placed to provide members with: expertise in negotiating and procurement, within the scholarly communications sector. "
target parent: EQT
target: SpringerProtocols
SpringerProtocols combines the world’s largest collection of life sciences and bio-medicine protocols with advanced search functionality. Used primarily in the life sciences, the protocols provide sets of instructions that allow scientists to recreate experiments in their own laboratories.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/7/2013 via Wall Street Journal

Wilmington Group plc, acquired NHiS Ltd

synopsis: Wilmington Group plc, the provider of Information, Compliance, and Education to professional markets announced the acquisition of the entire issued and to be issued share capital of NHiS Limited. NHiS is a leading provider of business intelligence, data analysis, workflow tools and other services to pharmaceutical companies in the UK.
buyer: Wilmington Group plc (LSE:WIL:$162.62)
Wilmington Group plc is a dynamic and expanding company providing information and training to professional business markets. Their businesses enable professionals and their organizations to perform better by providing quality, relevant and reliable information, education and knowledge. "
target: NHiS Ltd
NHiS is the leading provider of market intelligence and insight to the pharmaceutical sector. NHiS’s products assist organizations in their understanding, engagement and optimization of their markets.
price ($mm)
$8.82
rev ($mm)
$3
EBITDA ($mm)
EV / rev
5.2x
EV / EBITDA
closed 9/13/2011 via PR Newswire

ImpactRx, Inc., acquired TargetRx, Inc.

synopsis: ImpactRx, a Symphony Technology Group company and the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that it has acquired 100% of TargetRx, Inc., a leading provider of insight into the drivers of physician behavior for pharmaceutical companies.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
target: TargetRx, Inc.
TargetRx, Inc. is a leading provider of insight into the drivers of physician behavior for pharmaceutical companies. The company offers a suite of solutions from pipeline to patent expiry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/3/2016 via PR Newswire

IMS Health Incorporated, acquired AlphaImpactRx, Inc

synopsis: Symphony Technology Group announced the closing of the sale of AlphaImpactRx, a leading provider of primary research and analytics-based insight for biopharmaceutical and consumer health companies to IMS Health, a global information and technology services company serving the healthcare industry.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target parent: Symphony Technology Group
target: AlphaImpactRx, Inc
AlphaImpactRx is the leading provider of primary research-based insights, analytics and solutions to pharmaceutical, consumer health and medical device companies. They provide market research to help its global healthcare clients make informed and business decisions to market their products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/18/2011 via PR Newswire

Symphony Technology Group, acquired ImpactRx, Inc.

synopsis: ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that Symphony Technology Group (STG), has acquired a majority ownership interest in the Company. STG is a leading private equity firm with a strategic focus on data, analytics and technology-enabled services companies.
buyer: Symphony Technology Group
Symphony Technology Group (STG) is a strategic private equity firm with the mission of investing in and building great software and services companies. STG also provides transformation expertise to enable its companies to deliver maximum value to its clients. "
target: ImpactRx, Inc.
ImpactRX annually captures three-million treatment decisions, fueling its unique ImpactData™ industry database. ImpactRx leverages this unprecedented intelligence with custom research and analytics to provide insightful solutions to pharmaceutical marketing and sales decision makers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/22/2020 via PR Newswire

Clarivate Analytics, will acquire Decision Resources Group

synopsis: Clarivate Analytics plc, a global leader in providing trusted insights and analytics, will acquire Decision Resources Group ("DRG"), a premier provider of high-value data, analytics and insights products and services to the healthcare industry, from Piramal Enterprises Limited, part of global business conglomerate Piramal Group.
buyer: Clarivate Analytics (:$1,614.03)
Clarivate Analytics is a research analytics software company that provides subscription-based services in research and patent analytics. Organizations and researchers rely on the knowledge bases from Clarivate for information about pharmaceutical and biotech intelligence and IP management. "
target parent: Piramal Group
target: Decision Resources Group
Decision Resources Group (DRG) is uniquely positioned to help healthcare businesses improve the lives of patients around the world by creating patient-centric commercial strategies that drive better outcomes and better access.
price ($mm)
$950
rev ($mm)
$207
EBITDA ($mm)
$48
EV / rev
4.6x
EV / EBITDA
20.0x
closed 12/16/2015 via BNC Analysis

Sudler & Hennessey, acquired System Analytic Ltd.

synopsis: Sudler & Hennessey, has acquired a majority stake in System Analytic for an undisclosed sum. Sudler is a global healthcare marketing and communications network, while London-based System Analytic’s database and online tools enable pharmaceutical companies to identify, map and engage key opinions leaders across a broad range of medical fields.
buyer parent: WPP Group, plc
buyer: Sudler & Hennessey
Sudler & Hennessey is one of the world's leading healthcare communications firms, developing strategic promotional and educational programmes for a broad array of healthcare brands. "
target: System Analytic Ltd.
System Analytic Ltd. owns and operates a database and online tools to help pharmaceutical companies to identify and engages opinion leaders. The company was incorporated in 2006 and is based in London, United Kingdom.
price ($mm)
rev ($mm)
$3
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 3/24/2016 via PR Newswire

Sudler & Hennessey, acquired Viscira, LLC

synopsis: Sudler & Hennessey Group, a global healthcare communications network, announced the acquisition of Viscira, a leader in digital marketing and cutting-edge media in the healthcare space. Viscira develops visually-stunning, interactive solutions that provide unique, differentiated, and compelling communication delivery for the life sciences industry.
buyer parent: WPP Group, plc
buyer: Sudler & Hennessey
Sudler & Hennessey is a leading healthcare communications firm that develops strategic promotional and educational programs for a wide spectrum of healthcare brands. S&H creates advertising, direct marketing, and sales promotion programs for prescription drugs and over-the-counter medications. "
target: Viscira, LLC
Viscira is dedicated to the design and development of new-media communication solutions and interactive software applications for the life-sciences industry. They provide a suite of programs that integrate best-in-class technology to deliver engaging and memorable content via electronic channels.
price ($mm)
rev ($mm)
$17
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 12/16/2015 via BNC Analysis

Sudler & Hennessey, acquired System Analytic Ltd.

synopsis: Sudler & Hennessey, has acquired a majority stake in System Analytic for an undisclosed sum. Sudler is a global healthcare marketing and communications network, while London-based System Analytic’s database and online tools enable pharmaceutical companies to identify, map and engage key opinions leaders across a broad range of medical fields.
buyer parent: WPP Group, plc
buyer: Sudler & Hennessey
Sudler & Hennessey is one of the world's leading healthcare communications firms, developing strategic promotional and educational programmes for a broad array of healthcare brands. "
target: System Analytic Ltd.
System Analytic Ltd. owns and operates a database and online tools to help pharmaceutical companies to identify and engages opinion leaders. The company was incorporated in 2006 and is based in London, United Kingdom.
price ($mm)
rev ($mm)
$3
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 6/9/2021 via Company Press Release

Lucid Group, acquired DiD Agency

synopsis: UK-based Lucid Group, a global multi-capability healthcare communications company, has acquired DiD Agency Group, a full-service healthcare creative agency. The acquisition will strengthen Lucid Group’s existing presence in the US and its ability to provide a compelling strategic, creative and digital offering globally.
buyer: Lucid Group
Based in the UK, Lucid Group is a global multi-capability healthcare communications company committed to advancing patient health outcomes. Lucid Group’s pioneering approaches to communication have received industry-wide recognition and have consistently led to market-leading growth. "
target: DiD Agency
DiD Agency Group is a full-service healthcare creative agency. DiD offers extensive capabilities in a wide range of disease areas, including market strategy, strategic communications, creative execution, media and analytics, and an on-demand studio.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/11/2020 via Company Press Release

BresMed Health Solutions Ltd, acquired Cello Health plc

synopsis: Arsenal Capital Partners, a specialized private equity firm investing in healthcare and industrials companies, has acquired Cello Health plc, the global healthcare-focused advisory firm. Cello Health’s capabilities and culture are highly complementary with those of BresMed, a leader in health economic research acquired by Arsenal.
buyer parent: Arsenal Capital Partners
buyer: BresMed Health Solutions Ltd
BresMed is a health economic and outcomes research consultancy that provides health economic solutions to the global pharmaceutical industry. Established in 2006, BresMed has more than 150 staff across offices in the U.K., Ireland, the Netherlands, the U.S., and India. "
target: Cello Health plc (CLLL:$204.91)
Cello Health is a global healthcare-focused advisory firm comprised of a set of leading scientific, commercial advisory and digital delivery capabilities. Cello Health enables clients to commercialise, differentiate their assets, and drive brand success.
price ($mm)
$237
rev ($mm)
$218
EBITDA ($mm)
$14
EV / rev
1.1x
EV / EBITDA
17.2x
closed 11/26/2019 via Company Press Release

UDG Healthcare plc, acquired Canale Communications

synopsis: UDG Healthcare, an Ireland-based global leader in healthcare advisory, communications, commercial, clinical and packaging services, has acquired Canale Communications, a strategic communications and creative firm exclusively serving the life science and healthcare industries.
buyer: UDG Healthcare plc (LSE:UDG:$1,298.52)
Headquartered in Ireland, UDG Healthcare is a global leader in healthcare advisory, communications, commercial, clinical and packaging services. The Group is organised and managed across two divisions: Ashfield and Sharp, and employs 8,700 people in 26 countries. "
target: Canale Communications
Canale Communications is a strategic communications and creative firm exclusively serving the life science and healthcare industries. It has worked with more than 300 biotech, health tech, and pharmaceutical companies at virtually every stage of development.
price ($mm)
$20
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/17/2018 via BusinessWire

Huntsworth PLC, acquired Giant

synopsis: Shamrock Capital, a Los Angeles-based investment firm, announced the completion of the Giant Creative Strategy LLC acquisition by Huntsworth plc. Giant Creative Strategy is one of the largest independent healthcare marketing agencies based on the west coast.
buyer: Huntsworth PLC (LSE:HNT:$342.69)
Huntsworth PLC is an international healthcare and communications group. The Group's principal area of focus is Health, which provides marketing and medical communications services to healthcare clients, which are primarily large and mid-size pharmaceutical and biotech companies. "
target parent: Shamrock Capital Advisors, Inc.
target: Giant
Headquartered in San Francisco, Giant Creative Strategy is one of the largest independent healthcare marketing agencies based on the west coast. Giant specializes in strategy, creative and technology-driven multichannel marketing communications for its clients.
price ($mm)
$72*
rev ($mm)
$32
EBITDA ($mm)
$7
EV / rev
2.5x
EV / EBITDA
11.4x
closed 10/4/2012 via BNC Analysis

Healthcare Consultancy Group, acquired Chameleon Communications

synopsis: Healthcare Consultancy Group has acquired London based Chameleon Communications International, provider of strategic marketing, medical and regulatory advisory services.
buyer parent: Omnicom Group Inc.
buyer: Healthcare Consultancy Group
The Healthcare Consultancy Group is a leading provider of services to the pharmaceutical industry, including strategic medical education and scientific services, thought leader engagement, disease and product communications and regulatory advisory and support services. "
target: Chameleon Communications
Chameleon Communications has established a reputation for providing the highest quality global scientific communication services on behalf of the pharmaceutical industry and healthcare community.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/5/2012 via PR Newswire

GolinHarris, will acquire Virgo HEALTH

synopsis: GolinHarris, a division within Interpublic Group, announced it will acquire Virgo HEALTH, the award-winning, independent UK healthcare communications firm, to become part of the GolinHarris network. Virgo HEALTH will retain its name. Founders and joint chief executives Angie Wiles and Sarah Matthew will continue in their current roles.
buyer parent: Interpublic Group of Companies, Inc.
buyer: GolinHarris
GolinHarris is a holistic communications firm designed and built to help clients win in a complex, connected society. In 2011, GH completely redesigned the agency to combine strategy, creativity and engagement into one seamless package that is delivered to clients. "
target: Virgo HEALTH
Virgo HEALTH is one of the UK's leading independent healthcare communications consultancies. With a core proposition of Communications Without Compromise, Virgo provides a genuinely uncompromised service where the exceptional is always the rule.
price ($mm)
rev ($mm)
$9
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 5/11/2012 via BNC Analysis

McCann Healthcare Worldwide Japan, acquired MDS Co

synopsis: CMIC has concluded the agreements with McCann Healthcare Worldwide Japan, a Japanese subsidiary of one of the top three healthcare marketing communications networks in the world, on partially transferring shares of stock of its consolidated subsidiary company, MDS Co., Ltd. MDS provides marketing support services to pharmaceutical companies.
buyer parent: Interpublic Group of Companies, Inc.
buyer: McCann Healthcare Worldwide Japan
McCann Healthcare Worldwide Japan is a healthcare communications agency which is a part of McCann Worldgroup, a global marketing solutions company, characterized by its marketing know-hows that cover not only the pharmaceutical industry but the healthcare industry as a whole. "
target parent: CMIC Co., Ltd.
target: MDS Co
MDS, Co., Ltd. provides marketing support services to pharmaceutical companies through strategic planning and production of promotion materials for pharmaceutical products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/8/2011 via Market Wire

DisplayWorks LLC, acquired Millennium Communications Group, LLC

synopsis: Woodbridge Group announced the sale of its client Millennium Communications Group, LLC (MCG) based in Parsippany, New Jersey to DisplayWorks LLC. MCG is a leading provider of innovative marketing, training, medical education and multimedia solutions to the pharmaceutical industry for over 15 years.
buyer parent: JPB Capital Partners
buyer: DisplayWorks LLC
DisplayWorks produces exhibits, educational centers and events for a range of industries, and has a significant presence in the healthcare sector. The company is a portfolio holding of JPB Partners based in Columbia, Maryland. "
target parent: Woodbridge Group, LLC.
target: Millennium Communications Group, LLC
Millennium Communications Group is a provider of innovative marketing, training, medical education and multimedia solutions to the pharmaceutical industry. It provides Account Services, Content & Instructional Design Services, Technology Services, and HR/Employee Communications.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/1/2011 via PR Newswire

Hybrid Fuels, Inc., acquired EMG Marketing Solutions, Inc.

synopsis: Hybrid Fuels, Inc. announced that it has acquired 100% of the shares of EMG Marketing Solutions, Inc., a Florida corporation, that is focused on providing sales, marketing and product development expertise to the multi-billion dollar nutraceutical and pharmaceutical industry.
buyer: Hybrid Fuels, Inc. (HRID:$0.00)
Hybrid Fuels was incorporated in the state of Nevada in 1998 as Polo Equities. It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies. "
target: EMG Marketing Solutions, Inc.
EMG Marketing Solutions, Inc. is a Florida corporation that is focused on providing sales, marketing and product development expertise to the multi-billion dollar nutraceutical and pharmaceutical industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/29/2019 via BNC Analysis

Cult Collective LP, acquired Red Dragon Marketing

synopsis: Cult Collective, a premier marketing services firms devoted to helping brands achieve irrational customer loyalty and enjoy cult-like status, has acquired Red Dragon Marketing. Red Dragon specializes in marketing for the healthcare, cannabis and construction industries.
buyer: Cult Collective LP
Cult Collective is one of North America's premier marketing services firms devoted to helping brands achieve irrational customer loyalty and enjoy cult-like status. Cult Collective helps brands remain relevant in a world where consumers have too many choices and too little time. "
target: Red Dragon Marketing
Red Dragon Marketing Inc. (RDM) is a full-service marketing firm. They specialize in the delivery of digital and traditional marketing services for the healthcare, cannabis, and construction industries across North America.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/30/2019 via BNC Analysis

TransCanna, will acquire Goodfellas Group

synopsis: TransCanna Holdings Inc. is pleased to announce that it has signed a non-binding Letter of Intent to acquire Goodfellas Group, LLC, a full service advertising and marketing agency for the cannabis and hemp industries, from which the Company is already acquiring 23 branding agreements.
buyer: TransCanna (CNSX:TCAN:$0.00)
TransCanna specializes in assisting cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. They offer our services throughout every aspect of the ecosystem; from branding and design, to transportation and distribution, to marketing and sales. "
target: Goodfellas Group
The Goodfellas Group is a full service advertising and management agency that builds and sustains lasting brands. The Goodfellas team of experts help company owners develop, market, and retail licensed cannabis and cannabis-related products.
price ($mm)
$0.52
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/4/2018 via Company Press Release

Ashfield Commercial & Medical Services, acquired Create NYC

synopsis: UDG Healthcare plc, a leading international healthcare services provider, is pleased to announce the acquisition of Create NYC, a New York-based disruptive creative communications agency. The business will become part of UDG's Ashfield Communications, a global leader in commercialisation services for the pharmaceutical and healthcare industry.
buyer parent: UDG Healthcare plc
buyer: Ashfield Commercial & Medical Services
Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry. They provide field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services. "
target: Create NYC
Create NYC is an innovative New York-based healthcare creative communications agency, offering the tactical execution of sales and marketing materials for its international pharmaceutical clients.
price ($mm)
$58
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/3/2016 via Company Press Release

BCD Meetings & Events, acquired Plan 365, Inc.

synopsis: BCD Meetings & Events, a company that energizes and streamlines the business of meetings and incentives by offering event-level and enterprise-level solutions, has acquired Plan 365, Inc., a marketing logistics agency specializing in pharmaceutical and high-tech industries.
buyer: BCD Meetings & Events
BCD Meetings & Events energizes and streamlines the business of meetings and incentives by offering event-level and enterprise-level solutions. Headquartered in Chicago, BCD Meetings & Events has more than 1,000 resources in over 40 countries, with sales exceeding US $620 million. "
target: Plan 365, Inc.
Plan 365, Inc. is a marketing logistics agency specializing in pharmaceutical and high-tech industries. Plan 365, based in Raleigh, NC, offers go-to-market implementation services that help clients launch, scale and operationalize their go-to-market strategies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/24/2014 via Company Press Release

Communisis plc, will acquire Life Marketing Consultancy Limited

synopsis: Communisis plc, announces that it has entered into an unconditional agreement to acquire the entire share capital of Life Marketing Consultancy Limited. Life is an award-winning, research and insight-led shopper marketing agency. Life's clients are leading consumer goods groups especially in the food, drinks, technology and pharmaceutical sectors.
buyer: Communisis plc (GB:CMS:$501.10)
Communisis is a UK leading provider of personalised customer communication services that specialises in helping clients communicate with their customers more effectively and more profitably in fast-changing markets. "
target: Life Marketing Consultancy Limited
Life is an award-winning, research and insight-led shopper marketing agency. Life's clients are leading consumer goods groups especially in the food, drinks, technology and pharmaceutical sectors.
price ($mm)[EV]
$22 [$21]
rev ($mm)
$12
EBITDA ($mm)
$2
EV / rev
3.0x
EV / EBITDA
21.1x
closed 9/9/2014 via PR Newswire

Adelphi Group, acquired The Planning Shop International

synopsis: Adelphi Worldwide, part of The DAS Group of Companies, a division of Omnicom Group, announced that it has acquired The Planning Shop international, a London-based healthcare brand and research agency.
buyer parent: Omnicom Group Inc.
buyer: Adelphi Group
Adelphi Group is the world-leading, insight-led, multi- perspective, marketing services solutions group. It specializes in the healthcare sector, offering services in strategic marketing, marketing and business intelligence, real world observational research and disease specific programs and more. "
target: The Planning Shop International
The Planning Shop international is a global specialist healthcare brand strategy agency who provide unique consumer-based insight into every step of the product life cycle.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/30/2013 via Wall Street Journal

Saatchi & Saatchi Wellness, acquired Heartbeat Ideas

synopsis: Publicis Groupe announced that Heartbeat Ideas, one of the largest and most highly regarded digital agencies in the healthcare communications space, has joined the Saatchi & Saatchi Health entities in the U.S. to form a wholly new market player with unmatched strength and depth.
buyer parent: Publicis Groupe SA
buyer: Saatchi & Saatchi Wellness
Saatchi & Saatchi Wellness is a fully integrated wellness agency. The agency provides a full-range of marketing solutions including advertising, digital, direct promotion and social marketing strategies. Saatchi & Saatchi Health Communications and Saatchi & Saatchi Wellness operate as one entity. "
target: Heartbeat Ideas
Heartbeat Ideas is a pure interactive agency, built from the ground up to help clients prosper in the digital age. They design distinctive brand assets and websites that engages their clients' core constituents and trigger viral media, track blogs and construct eCRM programs.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/28/2012 via BNC Analysis

Creston Health, acquired DJM Digital Solutions Ltd

synopsis: Creston plc announced the acquisition of 75 percent of the share capital of DJM Digital Solutions Ltd, a UK-based digital healthcare agency. Creston's Health division and DJM have had a successful trading relationship and have many clients in common.
buyer parent: Creston plc
buyer: Creston Health
Creston Health unites some of the best known and most established agencies in the healthcare sector to deliver innovative and leading edge thinking to clients' global brands and organisations. "
target: DJM Digital Solutions Ltd
DJM Digital Solutions Ltd is a UK-based digital healthcare agency. Providing innovative creative, technology and digital solutions, it helps clients engage with their audiences using the most advanced communications platforms.
price ($mm)
$1.92*
rev ($mm)
$1
EBITDA ($mm)
EV / rev
5.7x
EV / EBITDA
closed 6/5/2012 via PR Newswire

inVentiv Health, Inc., acquired Kazaam Interactive

synopsis: inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, announced that it has acquired Kazaam Interactive, a full-service interactive agency providing comprehensive solutions and services for healthcare agencies and brands.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: inVentiv Health, Inc.
inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv's client roster includes more than 550 pharmaceutical, biotech and life sciences companies. "
target: Kazaam Interactive
Kazaam is a full-service digital marketing agency offering premier digital strategy and solutions to brands and organizations. The company has worked with over sixty of the world's largest brands and brings a real-world understanding for utilizing the online channels.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/22/2012 via PR Newswire

Publicis Healthcare Communications Group, acquired U-Link Business Solutions Co. Ltd

synopsis: Publicis Groupe announced that it has acquired U-Link Business Solutions Co. Ltd (UBS), one of the leading Chinese agencies specialized in healthcare communications. UBS will become part of Publicis Healthcare Communications Group and will be renamed UBS Saatchi & Saatchi Health.
buyer parent: Publicis Groupe SA
buyer: Publicis Healthcare Communications Group
Publicis Healthcare Communications Group is the largest health-oriented agency network in the world. It manages top-tier agencies specializing in promoting innovative solutions in advertising, medical education, sales and marketing, digital, and more. "
target: U-Link Business Solutions Co. Ltd
U-Link Business Solutions Co. Ltd is a full-service agency specializing in pharmaceutical PR, marketing and events management. It uses in-depth market intelligence to deliver industry-leading services through brand management and marketing, creative design, and much more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/31/2020 via BusinessWire

Evaluate Ltd., acquired Black Swan Analysis

synopsis: Evaluate, a company that provides trusted commercial intelligence for the pharmaceutical industry, has acquired Black Swan Analysis, a unique analysis practice that provides a turnkey solution to companies that may be resource restricted with limited capacity to provide a robust valuation for their healthcare products.
buyer: Evaluate Ltd.
Evaluate provides trusted commercial intelligence for the pharmaceutical industry. They help their clients to refine and transform their understanding of the past, present and future of the global pharmaceutical market to drive better decisions. "
target: Black Swan Analysis
Based in the UK, Black Swan Analysis is a unique analysis practice that provides a turnkey solution to companies that may be resource restricted with limited capacity to provide a robust valuation for their healthcare products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like System Analytic Ltd.


read more

System Analytic Ltd.

Avalere Health LLC

Decision Resources, Inc.

Decision Resources, Inc.

The Boz Group

MedicalDirector

Dymaxium, Inc.

Vidal Group

MedicalDirector

Decision Resources Group

Edital

Prous Science

Infinata, Inc.

Pharmaspectra

SpringerProtocols

NHiS Ltd

TargetRx, Inc.

AlphaImpactRx, Inc

ImpactRx, Inc.

Decision Resources Group

read more

System Analytic Ltd.

read more

Viscira, LLC

System Analytic Ltd.

read more

DiD Agency

Cello Health plc

Canale Communications

Giant

Chameleon Communications

Virgo HEALTH

MDS Co

Millennium Communications Group, LLC

EMG Marketing Solutions, Inc.

Red Dragon Marketing

Goodfellas Group

Create NYC

Plan 365, Inc.

Life Marketing Consultancy Limited

The Planning Shop International

Heartbeat Ideas

DJM Digital Solutions Ltd

Kazaam Interactive

U-Link Business Solutions Co. Ltd

Black Swan Analysis

Geography
Matching Companies
Ticker: OTCPK:HVST
 
 
 
 
 
 
 
 
First Harvest Corp.
First Harvest is a platform for tech, media and gaming with a focus on the cannabis industry. It spans mobile gaming, digital and social media, e-commerce sales and education. Their platform connects mainstream advertisers to pro-legalization supporters of medical and therapeutic cannabis.
year
2017
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($4.41)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OTCPK:INND
 
 
 
 
 
 
 
 
InnerScope Advertising Agency, Inc.
InnerScope Advertising Agency, Inc.
InnerScope Advertising Agency, Inc. was initially formed to monetize the experience of their founders in generating traffic through the front doors of hearing aid dispensing practices by providing advertising and marketing and design services that are unique to the industry.
year
2017
rev ($mm)
$1.56
EBITDA ($mm)
EBIT ($mm)
($0.99)
Net Income ($mm)
Employees
5
  • drill down
  • watch